Concert Pharmaceuticals Receives $50M Payment from Auspex Pharmaceuticals

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it hasreceived a payment of $50.2 million from Auspex Pharmaceuticals, Inc. Thepayment is pursuant to a September 2011 patent assignment agreement betweenConcert and Auspex whereby Concert assigned to Auspex a U.S. patentapplication relating to deuterium-substituted analogs of pirfenidone. Underthe agreement, Concert became eligible to receive the payment due to achange of control of Auspex, which was acquired by Teva PharmaceuticalsIndustries Ltd on May 5, 2015.

27% profits every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!